Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Standalone optical frequency-offset locking electronics for atomic physics.

The Review of scientific instruments·2026
Same author

Intergenerational transmission of child maltreatment among Black families: A scoping review.

Child abuse & neglect·2025
Same author

Review of Conventional and High Dose Rate Brain Radiation (FLASH): Neurobehavioural, Neurocognitive and Assessment Issues in Rodent Models.

Clinical oncology (Royal College of Radiologists (Great Britain))·2021
Same author

MR Imaging Characteristics of Intraocular Perfluoro-n-Octane.

AJNR. American journal of neuroradiology·2020
Same author

The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2019
Same author

Cognitive deficits and increases in creatine precursors in a brain-specific knockout of the creatine transporter gene Slc6a8.

Genes, brain, and behavior·2018

Related Experiment Video

Updated: Jun 7, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Heliox, dyspnoea and exercise in COPD.

T Hunt1, M T Williams, P Frith

  • 1Dept of Respiratory Medicine, Repatriation General Hospital, University of South Australia, Adelaide, Australia. toby.hunt@health.sa.gov.au

European Respiratory Review : an Official Journal of the European Respiratory Society
|October 20, 2010
PubMed
Summary
This summary is machine-generated.

Heliox, a helium-oxygen gas mixture, significantly improves exercise intensity and endurance for individuals with chronic obstructive pulmonary disease (COPD). While it enhances physical performance, its effect on reducing dyspnea sensation during exercise requires further investigation.

More Related Videos

Dual Test Gas Pulmonary Diffusing Capacity Measurement During Exercise in Humans Using the Single-Breath Method
08:44

Dual Test Gas Pulmonary Diffusing Capacity Measurement During Exercise in Humans Using the Single-Breath Method

Published on: February 2, 2024

Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise
07:09

Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise

Published on: February 20, 2017

Related Experiment Videos

Last Updated: Jun 7, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Dual Test Gas Pulmonary Diffusing Capacity Measurement During Exercise in Humans Using the Single-Breath Method
08:44

Dual Test Gas Pulmonary Diffusing Capacity Measurement During Exercise in Humans Using the Single-Breath Method

Published on: February 2, 2024

Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise
07:09

Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise

Published on: February 20, 2017

Area of Science:

  • Pulmonary Medicine
  • Respiratory Physiology
  • Exercise Science

Background:

  • Physical activity is crucial for the well-being of individuals with chronic obstructive pulmonary disease (COPD).
  • Altering dyspnea (shortness of breath) during exercise may enhance exercise capacity in COPD patients.
  • Helium-oxygen (Heliox) gas mixtures are being explored for their therapeutic potential in obstructive lung diseases.

Purpose of the Study:

  • To systematically review existing evidence on the effects of Heliox inhalation on symptom modification and exercise performance in COPD patients.
  • To assess if Heliox impacts perceived dyspnea levels and exercise intensity or duration during physical activity.

Main Methods:

  • Systematic review of peer-reviewed experimental studies.
  • Inclusion of eight studies investigating Heliox effects in COPD.
  • Analysis of outcomes related to perceived dyspnea and exercise performance metrics.

Main Results:

  • High-level evidence with low risk of bias supports Heliox's effectiveness in improving exercise intensity and endurance compared to room air for COPD patients.
  • Varied methodologies across studies limited direct comparisons and precluded meta-analysis.
  • Inconclusive evidence regarding Heliox's impact on reducing the sensation of dyspnea during exercise.

Conclusions:

  • Heliox demonstrates effectiveness in enhancing exercise performance (intensity and endurance) for individuals with COPD.
  • Further research is needed to definitively establish Heliox's role in mitigating exercise-induced dyspnea in COPD.
  • Heliox represents a potential adjunct therapy for improving exercise capacity in COPD management.